HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Kolben Selected Research

Estrogen Receptors

9/2023Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.
2/2021First Evidence for a Role of Siglec-8 in Breast Cancer.
12/2018Interaction of ERĪ± and NRF2 Impacts Survival in Ovarian Cancer Patients.
1/2016Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Kolben Research Topics

Disease

23Neoplasms (Cancer)
02/2024 - 06/2016
13Breast Neoplasms (Breast Cancer)
02/2024 - 02/2012
11Ovarian Neoplasms (Ovarian Cancer)
09/2023 - 06/2016
6Spontaneous Abortion (Miscarriage)
11/2021 - 01/2018
6Habitual Abortion (Recurrent Miscarriage)
11/2021 - 01/2018
5Ovarian Epithelial Carcinoma
01/2022 - 10/2020
4Gestational Diabetes (Gestational Diabetes Mellitus)
11/2023 - 10/2020
4Neoplasm Metastasis (Metastasis)
01/2023 - 10/2020
4Pre-Eclampsia (Preeclampsia)
01/2022 - 01/2019
3Inflammation (Inflammations)
03/2024 - 10/2020
3Carcinogenesis
09/2023 - 01/2019
3Uterine Cervical Dysplasia
08/2023 - 01/2017
3Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2023 - 02/2019
2Autoimmune Diseases (Autoimmune Disease)
11/2023 - 01/2021
2Endometrial Neoplasms (Endometrial Cancer)
12/2022 - 10/2019
1Disease Progression
07/2023
1Viral Pneumonia
10/2022
1COVID-19
10/2022
1Obesity
10/2022
1Overweight
10/2022
1Uterine Neoplasms (Uterine Cancer)
08/2020
1Hydatidiform Mole (Molar Pregnancy)
01/2020
1Chorioamnionitis
01/2019
1Rupture
01/2019
1Abruptio Placentae (Placental Abruption)
01/2019
1Fetal Distress
01/2019
1Squamous Intraepithelial Lesions
01/2017
1Osteoporosis
02/2012

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
03/2024 - 12/2018
6Galectins (Galectin)IBA
03/2024 - 04/2020
6Messenger RNA (mRNA)IBA
11/2021 - 12/2018
4Estrogen ReceptorsIBA
09/2023 - 01/2016
4histone H3 trimethyl Lys4IBA
01/2022 - 08/2020
4CytokinesIBA
11/2021 - 10/2020
4ProstaglandinsIBA
12/2020 - 01/2018
3ParaffinIBA
02/2024 - 07/2020
3Hormones (Hormone)IBA
02/2024 - 02/2012
3CateninsIBA
01/2023 - 08/2020
3Dinoprostone (PGE2)FDA Link
06/2020 - 01/2018
2Formaldehyde (Formol)FDA Link
02/2024 - 07/2020
2Co-Repressor ProteinsIBA
09/2023 - 07/2020
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
09/2023 - 01/2018
2Platelet Activating FactorIBA
01/2023 - 06/2021
2Sialyl Lewis X AntigenIBA
12/2022 - 01/2017
2CA-19-9 Antigen (CA 19-9 Antigen)IBA
12/2022 - 01/2017
2Sirtuin 1IBA
01/2022 - 08/2020
2Mucin-1 (CA 15-3 Antigen)IBA
02/2021 - 01/2020
2LigandsIBA
01/2021 - 07/2020
2Interleukin-7 (Interleukin 7)IBA
01/2021 - 10/2020
2Protein Isoforms (Isoforms)IBA
01/2021 - 01/2021
2Vitamin DFDA LinkGeneric
10/2020 - 06/2016
2FSH Receptors (FSH Receptor)IBA
10/2019 - 06/2019
1ErbB Receptors (EGF Receptor)IBA
02/2024
1GTP-Binding Proteins (G-Protein)IBA
09/2023
1Chemokine CCL22IBA
08/2023
1RNA Splicing FactorsIBA
07/2023
1Blood Group Antigens (Blood Groups)IBA
12/2022
1Insulin (Novolin)FDA Link
10/2022
1Oxygen (Dioxygen)IBA
10/2022
1Galectin 4 (LGALS4)IBA
01/2022
1Cadherins (E-Cadherin)IBA
01/2022
1Retinoid X Receptors (Retinoid X Receptor)IBA
01/2022
1PlatinumIBA
01/2022
1Carboplatin (JM8)FDA LinkGeneric
01/2022
1ResveratrolIBA
01/2022
1Lysine (L-Lysine)FDA Link
11/2021
1Histones (Histone)IBA
11/2021
1Interleukin-18 (Interleukin 18)IBA
11/2021
1Biomarkers (Surrogate Marker)IBA
06/2021
1EnzymesIBA
06/2021
1Sialic Acid Binding Immunoglobulin-like LectinsIBA
02/2021
1platelet activating factor receptorIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1GlycodelinIBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1Phosphopyruvate Hydratase (Enolase)IBA
01/2021
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2021
1rupatadineIBA
01/2021
1CalciumIBA
10/2020
1Calcitriol Receptors (Calcitriol Receptor)IBA
10/2020
1Nuclear Receptor Co-Repressor 1IBA
07/2020
1human ERBB2 proteinIBA
01/2020
1Peptide Elongation Factors (Elongation Factor)IBA
01/2020
1Galectin 1 (LGALS1)IBA
10/2019
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
06/2019
1progesterone receptor BIBA
01/2019
1Progesterone Receptors (Progesterone Receptor)IBA
01/2019
1progesterone receptor AIBA
01/2019
1Fas Ligand Protein (Fas Ligand)IBA
02/2018
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2018
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2018
1Thyroid HormonesIBA
06/2016
1TamoxifenFDA LinkGeneric
02/2012
1Aromatase InhibitorsIBA
02/2012
1Diphosphonates (Bisphosphonates)IBA
02/2012

Therapy/Procedure

13Therapeutics
02/2024 - 02/2012
2Adjuvant Chemotherapy
02/2024 - 01/2016
1Contraindications
01/2019
1Segmental Mastectomy (Lumpectomy)
01/2018
1Colposcopes
01/2017